![]() |
|
|
Vol. 11, Issue 4, 1421-1432, April 2000
s
to the Golgi Complex Region

*Department of Pharmacology and Clinical Pharmacology, Medical
Faculty, Ankara University, 06100 Ankara, Turkey; and
Metabolic Diseases Branch, National Institute of Diabetes
and Digestive and Kidney Diseases, National Institutes of Health,
Bethesda, Maryland 20892
| |
ABSTRACT |
|---|
|
|
|---|
XL
s is a splice variant of the heterotrimeric G protein,
G
s, found on Golgi membranes in cells with regulated and
constitutive secretion. We examined the role of the alternatively
spliced amino terminus of XL
s for Golgi targeting with the use of
subcellular fractionation and fluorescence microscopy. XL
s
incorporated [3H]palmitate, and mutation of cysteines in
a cysteine-rich region inhibited this incorporation and lessened
membrane attachment. Deletion of a proline-rich region abolished Golgi
localization of XL
s without changing its membrane attachment. The
proline-rich and cysteine-rich regions together were sufficient to
target the green fluorescent protein, a cytosolic protein, to Golgi
membranes. The membrane attachment and Golgi targeting of the fusion
protein required the putative palmitoylation sites, the cysteine
residues in the cysteine-rich region. Several peripheral membrane
proteins found at the Golgi have proline-rich regions, including a
G
i2 splice variant, dynamin II,
III spectrin,
comitin, and a Golgi SNARE, GS32. Our results suggest that proline-rich
regions can be a Golgi-targeting signal for G protein
subunits and
possibly for other peripheral membrane proteins as well.
| |
INTRODUCTION |
|---|
|
|
|---|
Heterotrimeric G proteins are classically known to couple cell
surface receptors to various membrane-bound effectors (Gilman, 1987
;
Hamm and Gilchrist, 1996
). Each heterotrimer consists of an
subunit, which exchanges GDP for GTP upon activation by a receptor, and

subunits, which are tightly bound together. The
subunits
attach tightly to membranes through posttranslational lipid
modifications and binding to the relatively hydrophobic 
complex.
Different
subunits segregate into specific subdomains of the plasma
membrane (Stow et al., 1991
) and are also associated with
the membranes of different intracellular organelles (Jones, 1994
;
Denker et al., 1996
; Stow and Heimann, 1998
). Within the cell, G proteins are involved in vesicular transport between the endoplasmic reticulum and the Golgi (Beckers and Balch, 1989
; Hidalgo
et al., 1995
), through the Golgi stack (Melançon
et al., 1987
; Leyte et al., 1992
; Stow and
Heimann, 1998
), and other membrane-trafficking steps (Bomsel and
Mostov, 1992
). The functional consequences of receptor-G
protein-effector systems at selective membranes presumably require the
proper targeting of G proteins. The strong homology between
subunits makes their geographic diversity a puzzling trafficking problem.
Mutagenesis studies on targeting signals for
G
i2 and G
i3 (de
Almeida et al., 1994
) and the discovery of splice variations of
subunits that change their intracellular localization provide clues to this problem. XL
s (extra-large
s), a splice variant of
G
s, is particularly interesting because it is
found on Golgi membranes in cells with both regulated and constitutive
pathways of protein secretion (Kehlenbach et al., 1994a
,b
).
This protein, identified as a cholera toxin substrate, is identical to
G
s except for exon 1, at which a 347-amino
acid amino terminus replaces 47 amino acids in
G
s. The XL portion has proline-rich and
cysteine-rich regions and areas of EPAA and AARA repeats. Another
subunit splice variant, sG
i2, also resides on
Golgi membranes and is identical to G
i2 except
for the last exon, which encodes a different 35-amino acid,
proline-rich carboxy terminus (Montmayeur and Borrelli, 1994
).
The signals involved in the Golgi targeting of peripheral membrane
proteins, including G proteins, are poorly understood (reviewed by
Stanley, 1996
; Gleeson, 1998
; Munro, 1998
). Sorting signals on
intrinsic membrane proteins act to retain these proteins in the Golgi
apparatus or to retrieve them from the cell surface or other
organelles. The transmembrane domain is critical for retention in the
Golgi by proposed mechanisms that include oligomerization and sorting
based on the length of the transmembrane domain. Retrieval signals such
as the di-leucine motif are found on the cytoplasmic domains of
integral membrane proteins. For peripheral membrane proteins at the
Golgi, some transiently associate with ADP-ribosylation factor proteins
leading to translocation to Golgi membranes. For several coiled-coil
proteins, a Golgi-targeting domain, the GRIP domain, has been
identified in their carboxy termini (Barr, 1999
; Kjer-Nielsen et
al. 1999
; Munro and Nichols, 1999
). For others, regions have been
identified that are crucial for localization. Endothelial nitric oxide
synthase (eNOS), SCG10, and glutamate decarboxylase have
Golgi-localizing regions at their amino termini that also contain sites
for two or more lipid modifications (Solimena et al., 1994
;
Di Paolo et al., 1997
; Liu et al., 1997
).
Palmitoylation, the reversible addition of palmitate to cysteine
residues by a thioester bond, occurs on the amino terminus of G protein
subunits (Linder et al., 1993
) and has several functions. Palmitoylation increases receptor-G protein coupling and
the affinity of the
subunit for the 
complex (Iiri et al., 1996
; Ponimaskin et al., 1998
). For
G
s, receptor activation causes a rapid
turnover of palmitate, suggesting a role in signaling (Degtyarev
et al., 1993b
; Mumby et al., 1994
; Wedegaertner
and Bourne, 1994
). The importance of palmitoylation in gross membrane attachment is controversial (Wedegaertner et al., 1993
;
Huang et al., 1999
), but it may play a more subtle role in
targeting G proteins to membrane microdomains (Arni et al.,
1998
; Melkonian et al., 1999
). XL
s does not have the
acylation site found on G
s but does have a
cysteine-rich domain containing six cysteines that are potential sites
for palmitoylation.
We investigated the Golgi targeting of XL
s by studying two regions
in its XL amino terminus: the cysteine-rich region (CRR) and the
proline-rich region (PRR), which bears similarity to the proline-rich
carboxy terminus of sG
i2. We wished both to
better understand the mechanisms involved in G protein targeting and to
test the generality of the Golgi-localization signals suggested for
eNOS and sG
i2. We found that the PRR and the
cysteines in the CRR were critical for the Golgi targeting of XL
s.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell Culture
COS-7 and HEK-293 cells were grown in DMEM supplemented with penicillin (100 IU/ml), streptomycin (100 µg/ml), and 10% (vol/vol) FBS at 37°C in a humidified atmosphere of 5% CO2. PC12 cells were maintained in identical conditions except that the serum supplementation was 5% (vol/vol) FBS and 10% (vol/vol) heat-inactivated horse serum.
Plasmid Constructs and Mutagenesis
The cDNA coding the 715-amino acid rat XL
s (Kehlenbach
et al., 1994a
,b
) in a pCDNA3.1 (+) plasmid (Invitrogen,
Carlsbad, CA) underwent site-directed mutagenesis by a PCR-based
method, QuikChange (Stratagene, La Jolla, CA), except that Pwo
Polymerase (Boehringer Mannheim, Indianapolis, IN) was used. To
generate green fluorescent protein (GFP) fusion proteins, cDNAs
encoding the following regions of XL
s were amplified from wild-type
XL
s-pcDNA3.1 or the 2C and 0C cysteine-to-serine mutants with the
use of PCR: 1) PRR (amino acids 201-235); 2) PRR plus CRR (amino acids
201-312); and 3) CRR (amino acids 225-312). cDNAs were inserted into
the pEGFP N1 vector (Clontech, Palo Alto, CA) at a BamHI
site upstream and in frame with the cDNA coding EGFP. Mutations
were confirmed with the use of ABI PRISM dye terminator cycle
sequencing (Perkin Elmer-Cetus, Norwalk, CT).
Transient Transfection of the Cells
COS-7 cells, grown to subconfluence in
75-cm2 tissue culture flasks, were transfected
with the use of 2 µg of plasmid DNA per flask and the DEAE-dextran
method, as described (Butrynski et al., 1992
). PC12 cells,
suspended in 0.8 ml of RPMI-1640 at a density of 4 × 106 cells/ml, were transfected by electroporation
at 960 µF and 360 V with the use of a Bio-Rad (Hercules, CA) Gene
Pulser and 40-50 µg of plasmid DNA. Transfected PC12 cells were
seeded into two-well chamber slides in RPMI-1640 supplemented with 10%
FBS. The medium was changed to DMEM with 5% FBS and 10%
heat-inactivated horse serum after 24 h. Metabolic labeling and
immunodetection were performed 2 d after transfection. HEK-293
cells were transfected with the use of the LipofectAMINE PLUS reagent
(GIBCO-BRL/Life Technologies, Grand Island, NY).
[3H]Palmitate Labeling and Cell Fractionation
For metabolic labeling, cells were first incubated for 2 h
in serum-free DMEM and then in 5 ml of serum-free DMEM containing 500 µCi/ml [3H]palmitic acid (specific activity,
60 Ci/mmol; American Radiochemical, St. Louis, MO) for 50 min. Cells
were harvested by scraping in 45 ml of ice-cold PBS and centrifuged at
2000 × g for 10 min, and cell pellets were stored at
70°C. The pellets were lysed, homogenized, and fractionated into
particulate and soluble fractions by centrifugation at 125,000 × g for 1 h as described (Degtyarev et al.,
1993a
). Protein concentrations were determined with the use of the
Bio-Rad assay (Bradford, 1976
) with immunoglobulin G as the standard.
Immunoprecipitation and Immunoblotting
The polyclonal, affinity-purified antibody for G
s
(RM) and antibody for G
i (AS), which recognize the
carboxy-terminal decapeptide of G
s and XL
s
and the carboxy-terminal decapeptide of G
i,
respectively, were used (Jones et al., 1990
). Equal amounts
of protein (300-400 µg) from the particulate fractions were
incubated with the antibody in 500 µl of solubilization buffer (50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 1% [vol/vol] Triton X-100, 0.2%
[wt/vol] SDS, 1 mM EDTA) overnight at 4°C. The immunoprecipitates
were recovered by a 2-h incubation with protein A-Sepharose CL-4B
(Pharmacia LKB Biotechnology, Piscataway, NJ), washed, separated by
SDS-PAGE, and prepared for fluorography as described previously (Jones
et al., 1990
). Densitometry of the fluorographs was
performed with an AGFA Arcus II scanner (Pharmacia LKB Biotechnology)
and NIH Image software (http://rsb.info.nih.gov/nih-image/). For
immunoblots, 5 µg of protein from each particulate and
soluble fraction was separated by SDS-PAGE and transferred to
nitrocellulose paper. The proteins were detected with the RM antibody
(1 µg/ml) or a polyclonal antibody raised against the GFP (1:3000)
(Molecular Probes, Eugene, OR) and ECL (Amersham, Arlington Heights,
IL) as described by the manufacturer.
Cholera Toxin Labeling and Detergent Solubilization
Particulate fractions (75 µg of protein) were incubated with
300 mM potassium phosphate, pH 7.0, 10 mM thymidine, 1 mM ATP, 0.1 mM
GTP, 10 mM MgCl2, 1 mM EDTA, protease inhibitors,
6 µg of activated cholera toxin (Ribeiro-Neto et al.,
1985
), 1 mM DTT, 10 µg of purified brain 
subunits (Sternweis
and Robishaw, 1984
), 5 µM NAD, and 10 µCi of
[32P]NAD (specific activity, 1000 Ci/mmol;
Amersham) in a volume of 60 µl for 45 min at 37°C. The reaction was
stopped, and the samples were prepared for SDS-PAGE as described
(Ribeiro-Neto et al., 1985
). The gels were analyzed by
autoradiography and a Phosphorimager (Molecular Dynamics, Sunnyvale,
CA). Solubilization of proteins in the particulate fractions was
performed with 1% (vol/vol) Triton X-100 as described previously
(Jones and Gutkind, 1998
).
Immunocytochemistry and Fluorescence Microscopy
Cells, grown and transfected in two-well chamber slides, were
washed four times with PBS at room temperature, fixed and permeabilized by incubation in methanol at
20°C for 3 min, and washed four times
with PBS. Cells expressing the GFP fusion proteins were fixed with 2%
(wt/vol) paraformaldehyde in PBS for 20 min and permeabilized with
0.1% (wt/vol) Triton X-100 in PBS for 15 min. After incubation for 15 min in the blocking buffer (1% normal goat serum, 0.2% [vol/vol]
Triton X-100 in PBS), cells were incubated for 1 h at room
temperature in 0.1% (wt/vol) BSA in PBS with the RM antibody at 0.5 ng/ml and with the anti-58-kDa protein monoclonal mouse antibody (Sigma
Chemical, St. Louis, MO) at a 1:100 dilution. After washing four times
with 0.1% BSA in PBS, cells were incubated for 1 h at room
temperature with one of the following secondary antibodies (Jackson
ImmunoResearch, West Grove, PA): Cy3-labeled anti-rabbit (1:4000),
FITC-labeled anti-mouse (1:100), or Cy3-labeled anti-mouse (1:100)
antibody. Cells, washed four times with 0.1% BSA in PBS and once with
distilled water, were mounted in Prolong antifade reagent (Molecular
Probes) and visualized with the use of a Zeiss (Thornwood, NY) Axioskop
microscope equipped for fluorescence microscopy with a 63×, 1.4 numerical aperture Plan-Apochromat oil immersion objective or a Leica
(Wetzlar, Germany) LSM confocal microscope. For Golgi labeling of live
PC12 cells with BODIPY FL C5-ceramide (Molecular
Probes), the method described by Ktistakis et al. (1995)
was
used. For treatment with brefeldin A, transfected COS cells were
incubated with BODIPY TR ceramide (1 µM, mixed with equimolar
defatted BSA in serum-free DMEM; Molecular Probes) for 30 min at 4°C,
washed three times with DMEM with 10% FBS, and incubated at 37°C for
30 min. Brefeldin A (Epicentre Technologies, Madison, WI) was
added at a final concentration of 5 µM, and cells were incubated for
another 15 min, washed three times with PBS, and mounted and visualized
as described above.
Quantitative Analysis of the Immunofluorescence
Cells were counted if they were brightly stained with RM
antibody or GFP fluorescence, indicating that they had undergone transfection. The cells showing staining that colocalized with the
anti-58-kDa antibody staining of a dense, perinuclear area were counted
as positive with respect to the Golgi localization of XL
s proteins.
Transfections were done in parallel, and coded slides were used for
this quantitation.
| |
RESULTS |
|---|
|
|
|---|
Endogenous XL
s Undergoes Palmitoylation in PC12 Cells
G
s undergoes palmitoylation at its amino
terminus (Linder et al., 1993
). XL
s lacks the cysteine
residue at the third position of G
s that is
critical for the modification (Degtyarev et al., 1993a
) but
has six cysteines in a cysteine-rich domain of its so-called XL portion
(Figure 1A; Table
1). To determine if endogenous XL
s is
palmitoylated, PC12 cells were metabolically labeled with [3H]palmitic acid and proteins were
immunoprecipitated with the RM antibody, an antibody specific for the
carboxy terminus of G
s and XL
s (Figure 1A).
Tritium incorporation was seen in 94- and 42-kDa protein bands,
corresponding to the expected sizes of XL
s and
G
s, respectively (Figure 1B).
Immunoprecipitation with the AS antibody, a
G
i-specific antibody prepared in the same way
as the RM antibody, did not detect the 94-kDa band that is prominent in
the fluorograph of the labeled membranes. Under these conditions, the
tritium label incorporated into G
s is
[3H]palmitate (Degtyarev et
al.,1993a
), suggesting that XL
s is palmitoylated.
|
|
[3H]Palmitate Incorporation and Membrane Attachment
of XL
s Mutants in COS-7 Cells
We investigated whether palmitoylation occurred on the cysteines
in the CRR by creating a series of cysteine-to-serine mutants by
site-directed mutagenesis (Table 1). COS-7 cells were transfected with
vectors containing the wild-type and mutant XL
s cDNAs and incubated
with [3H]palmitate. The
G
s and XL
s proteins in the particulate
fraction were immunoprecipitated with the RM antibody. COS-7 cells
express the long and short forms of G
s seen as
45- and 42-kDa bands, respectively, in all the lanes but do not express
XL
s endogenously (Figure 2A). Cells
transfected with wild-type XL
s showed a band at 94 kDa strongly
labeled with tritium. Mutation of the six cysteine residues in the wild
type decreased the tritium incorporation into XL
s in a stepwise
manner for mutants 4C, 3C, and 2C (Figure 2A). Densitometry readings of
the 94-kDa bands for the 4C, 3C, and 2C mutants were 94, 85, and 60%,
respectively, that of the wild-type XL
s. The 1C and 0C mutants did
not show any tritium incorporation. A 64-kDa band seen in the
transfected cells was probably the product of a late initiation site at
residue 136. This protein band also showed a decrease in tritium
incorporation because it contains the CRR.
|
The transfected cells were separated into particulate and soluble
fractions followed by immunoblotting to test the
membrane attachment of the reduced-palmitoylation mutants (Figure 2, B and C). The wild-type XL
s and 4C, 3C, and 2C mutants were primarily in the particulate fraction and had minimal amounts of protein localized to the soluble fraction. However, the 1C and 0C mutants, which did not incorporate [3H]palmitate, were
found in both the soluble and particulate fractions. These results
indicate that these cysteine residues in the CRR were critical for
palmitoylation and facilitate membrane attachment, although
palmitoylation must not be the sole factor in membrane attachment.
Deletion of the PRR
XL
s is localized primarily to the Golgi (Kehlenbach et
al., 1994a
). We deleted the PRR in the wild-type XL
s and the
reduced-palmitoylation 2C mutant to create mutants that would test the
role of this region in intracellular localization (Figure 1; Table 1).
We chose the 2C mutant because its incorporation of
[3H]palmitate was impaired compared with that
of XL
s (Figure 2A), but it was still membrane attached (Figure 2, B
and C). The mutants with a deletion of the PRR (
PRR) were slightly
smaller than the wild-type XL
s but were expressed at levels
equivalent to those of the wild-type XL
s in COS-7 cells (Figure 2D).
The
PRR mutants were confined to the particulate fraction (Figure
2D) and showed no defects in incorporation of
[3H]palmitate. The 2C and
PRR mutants
underwent ADP-ribosylation catalyzed by cholera toxin and detergent
solubilization with Triton X-100 to the same degree as the wild-type
XL
s.
Intracellular Localization of XL
s Mutants
Localization of the reduced-palmitoylation and PRR-deletion
mutants of XL
s was determined with the use of indirect
immunofluorescence microscopy. We used an antibody specific to a
protein associated with the cytoplasmic surface of the Golgi, the
58-kDa protein, to identify the Golgi structure (Bloom and Brashear,
1989
). The RM antibody was used for the XL
s and
G
s proteins. In transfected COS cells, the
wild-type XL
s was localized to a compact perinuclear area that can
be identified as Golgi with the anti-58-kDa protein antibody (Figure
3, a and b). We also found colocalization
of endogenous and overexpressed XL
s with another Golgi marker,
BODIPY FL C5-ceramide (Ktistakis et
al., 1995
), in PC12 cells.
|
The reduced-palmitoylation mutants 4C, 3C, and 2C also showed bright, compact perinuclear staining that colocalized with the Golgi antibody staining (data shown for the 2C mutant in Figure 3, e and f). The 1C mutant, which did not undergo palmitoylation, exhibited a diffuse, cytosolic pattern consistent with its increased solubility but that obscured its membrane localization.
Deletion of the PRR in the XL portion of XL
s led to a significant
decrease in Golgi localization (Figure 3, c, d, g, and h). After
transfection with the
PRR and 2C
PRR mutants, only 19% of 120 cells examined and 14% of 122 cells examined, respectively, showed a
bright spot in the perinuclear area that colocalized with the Golgi
antibody. In comparison, 50% of 136 cells transfected with the
wild-type XL
s colocalized with the Golgi antibody staining in the
perinuclear region. The distribution pattern of the
PRR mutants was
comparable to the pattern of overexpressed G
s,
with staining predominantly on intracellular membranes and some plasma membrane staining (Figure 3, i and j). The
PRR mutants expressed in
PC12 cells were primarily found on the plasma membrane, with some
staining on other intracellular membranes but without prominent perinuclear staining.
Images were also obtained by confocal microscopy that showed the
colocalization of XL
s with anti-58-kDa Golgi staining (Figure 4A). The confocal images show more
clearly that the
PRR mutant was found on various intracellular
membranes, including a small amount on the Golgi that is seen in the
limited colocalization with the Golgi antibody (Figure 4B).
|
Membrane Attachment and Intracellular Localization of GFP Fusion Proteins
To further evaluate the roles of the PRR and the CRR as
Golgi-targeting signals for XL
s, we constructed fusion proteins with these regions and the GFP (Table 2) and
examined their membrane attachment and intracellular localization.
Immunoblotting of the particulate and soluble fractions
of transfected COS cell lysates with an antibody to GFP showed that GFP
alone and PRR and PRR+(0C)CRR fused to GFP were primarily soluble
proteins (Figure 5). In contrast, PRR+CRR, PRR+(2C)CRR, CRR, and (2C)CRR fused to GFP were primarily found in the particulate fraction, indicating that cysteines in the CRR
were needed to direct a soluble protein to the membrane fraction.
|
|
We then examined the intracellular distribution of fusion proteins by
direct fluorescence microscopy in live COS and HEK-293 cells (data
shown for COS cells in Figure 6). Cells
expressing the GFP protein displayed a diffuse fluorescence throughout
the cells (Figure 6a), consistent with previous reports demonstrating that GFP is expressed as a cytosolic protein. Diffuse cytosolic staining was also found for the PRR and PRR+(0C)CRR fusion proteins (Figure 6, b and e), consistent with the results from cell
fractionation (Figure 5). In contrast, fusion proteins containing PRR
together with CRR or (2C)CRR displayed a compact perinuclear
localization (Figure 6, c and d) that was consistent with Golgi
localization. For [PRR+CRR]-GFP, 87% of 101 cells examined showed
bright, perinuclear staining, and for [PRR+(2C)CRR]-GFP, 81% of 110 cells examined showed bright, perinuclear staining. The CRR and (2C)CRR
fusion proteins exhibited some perinuclear localization but also a
scattered intracellular fluorescence, presumably caused by nonspecific
localization of these fusion proteins to intracellular membranes
(Figure 6, f and g).
|
The Golgi localization of the PRR+CRR fusion protein was confirmed by
observing that GFP fluorescence colocalized with staining for the
58-kDa Golgi protein antibody in fixed COS cells (Figure 7, a and b). In addition, the GFP
fluorescence colocalized with BODIPY TR ceramide, a Golgi marker, in
live cells (Figure 7, c and d). Treatment of cells with brefeldin A,
which disintegrates the Golgi apparatus, abolished the perinuclear
staining of the PRR+CRR fusion protein (Figure 7, e and f).
|
Together, these data suggest that PRR could be a Golgi-targeting signal but that cysteines in the CRR were crucial for the attachment of otherwise soluble PRR to the Golgi membranes
| |
DISCUSSION |
|---|
|
|
|---|
Heterotrimeric G proteins work not only at the plasma membrane to
couple cell surface receptors to intracellular effectors but also at
the Golgi membrane to regulate vesicular transport (Gilman, 1987
;
Melançon et al., 1987
; Leyte et al., 1992
).
Consequently, these proteins must be sorted to their appropriate
intracellular sites. We found that the Golgi localization of XL
s, a
G
s splice variant, was determined by a PRR and
a CRR in its amino terminus.
The PRR of XL
s
Deletion of the PRR in XL
s led to a loss of its Golgi
localization after expression in PC12 cells with endogenous XL
s and in COS cells without the endogenously expressed protein. This protein
was still attached to membranes and folded properly, as measured by its
ability to undergo ADP-ribosylation catalyzed by cholera toxin. Fusion
of the PRR and CRR to the GFP, a cytosolic protein, was sufficient for
targeting to the Golgi membranes.
We initially chose to study this region because an alternatively
spliced form of G
i2 has a PRR in the carboxy
terminus and is found at the Golgi rather than at the plasma membrane,
as is G
i2 (Montmayeur and Borrelli, 1994
). The
sequence of the human form of XL
s was identified recently, and the
PRR was highly conserved between species (Table
3), although the intracellular
distribution of the human XL
s is not known.
|
Proline-rich peptides have unique properties based on the unusual side
chain of proline that circles back to the backbone amide position
(Williamson, 1994
). PRRs serve both structural and binding functions
for the diverse group of proteins that contain them. For XL
s, the
PRR may be a rigid spacer between the amino-terminal domain and the
cysteine-rich and
s domains. Deletion of the
PRR bridge may then change the global conformation to diminish the interaction with the Golgi membrane and/or a Golgi protein.
Alternatively, the PRR may be a site of direct binding to the Golgi.
PRRs are found on a number of proteins, and their restricted mobility
forms a "sticky arm" to facilitate protein-protein interactions
that are rapid and less specific than typical receptor-ligand
interactions that use "lock-and-key" binding (Williamson, 1994
).
This type of interaction is consistent with the results of our findings with a GFP fusion protein, in which the PRR and CRR alone could target
the GFP fusion protein to the Golgi membranes.
Could the PRR be a Golgi-targeting signal for other proteins? A
review of the literature uncovered several peripheral Golgi proteins
that contain PRRs (Table 3). However, the functions of the PRRs and the
Golgi-targeting signals (except for dynamin and
III spectrin; see
below and Table 3) are not known for these proteins. The abundance of
proline residues, rather than a consensus pattern, distinguishes these
regions. These proteins (except for dynamin) do not have known
proline-enriched consensus sequences such as XPPXY or PPLP for
WW domain binding, E/DFPPPXD/E for Ena-VASP homology domain 1 domain binding, or RXqPXqP or qPXqPXR for Src homology 3 domain binding
(X is any amino acid, and q is a hydrophobic residue) (Chen and Sudol,
1995
; Mayer and Eck, 1995
; Niebuhr et al., 1997
).
The PRR of dynamin has been carefully studied. Members of the dynamin
family are high-molecular-weight GTPases involved in the vesiculation
of clathrin-coated pits and are found on Golgi membranes as well as the
plasma membrane and other intracellular membranes (Jones and Gutkind,
1998
). Deletion of the proline-rich carboxy terminus abolishes
targeting to coated pits (Shpetner et al., 1996
), and an
isoform of dynamin lacking the proline-rich carboxy terminus does not
colocalize to the Golgi (Kamimoto et al., 1998
). SH3
domain-binding regions have been identified in this PRR, but the role
of these regions and other areas of the carboxy terminus in the
intracellular localization of the different isoforms of the protein has
not been reported (Okamoto et al., 1997
). Interestingly,
alternative splicing of dynamin, like XL
s and
G
s, can markedly change its intracellular
distribution (Cao et al., 1998
).
PRRs are involved in systems that require rapid and reversible
association of several proteins into functional complexes (Williamson, 1994
). Two well-characterized examples are the RNA polymerase II
preinitiation complex and proteins associated with synaptic vesicles
such as synapsins, VAMP-1, and synaptophysins. The PRRs of XL
s and
possibly other Golgi proteins may bind them into a Golgi-associated
"complex." Specificity for Golgi membranes may arise through
binding to isoforms of cytoskeletal proteins found at the Golgi (De
Matteis and Morrow, 1998
), because the binding target of PRRs is often
the cytoskeleton (Williamson, 1994
). For XL
s, the PRR alone was
insufficient to target the GFP fusion protein to the Golgi membranes,
suggesting that it required another factor, such as acylation, to
establish or maintain membrane attachment. Given the number of proteins
with PRRs, an additional signal may also be present within the PRR and
CRR to direct the protein to the Golgi membranes.
Palmitoylation of XL
s
Like most other
subunits, XL
s underwent palmitoylation, as
demonstrated by its ability to incorporate
[3H]palmitate. Unlike other
subunits, in
which the putative acylation sites are within the first 18 residues,
the likely sites of palmitoylation for XL
s are on 6 cysteine
residues within a CRR distant from the amino terminus, because mutation
of these cysteines blocked [3H]palmitate
incorporation. The nonpalmitoylated mutants were partially found in the
soluble fraction, indicating that palmitoylation facilitated membrane
attachment but was not required. The finding that the GFP fusion
protein containing the PRR and the CRR lacking the cysteine
residues was soluble suggests an additional site for membrane
attachment outside of the PRR and CRR. Whether membrane attachment
occurs through 
subunits, as it does for other
subunits, is
uncertain because the regions of
subunits that bind 
differ
between XL
s and G
s.
Palmitoylation occurs on many membrane-bound proteins, and for that
reason it cannot be a targeting signal by itself. However, palmitoylation is frequently found within or adjacent to a protein sequence that is critical for directing intracellular localization. For
XL
s, the CRR starts nine residues from the PRR. The importance of
acylation in Golgi targeting differs among proteins. For eNOS, acylation was critical for its Golgi localization (Liu et
al., 1997
). Yet for GAD65, mutation of all six cysteines adjacent
to the amino-terminal Golgi-targeting domain did not change its Golgi localization (Solimena et al., 1994
). Mutations to prevent
palmitoylation in another Golgi protein, SCG10, led to a small increase
in solubility and the concomitant difficulties in visualizing the
intracellular localization (Di Paolo et al., 1997
), as was
the case for the nonpalmitoylated mutant of XL
s. In this study, the
PRR was insufficient for Golgi localization, which required the
putative acylation sites in the CRR for targeting of the GFP fusion
protein. The proximity of acylation sites to targeting sequences may
aid in orienting the targeting signal toward the membrane and
preserving the contact. Differences among proteins in the role of
palmitoylation in Golgi targeting may be due to differences in the
affinity of the targeting sequence for the Golgi membrane.
Intracellular Localization and Function of XL
s
The intracellular localization of XL
s to the Golgi is based on
colocalization with two Golgi markers, an antibody to the 58-kDa
protein (Bloom and Brashear, 1989
) and BODIPY-TR ceramide (Ktistakis et al.1995
), and the loss of perinuclear staining
after treatment with brefeldin A, a fungal metabolite that disrupts Golgi membranes. The compact pattern of the staining may indicate that
it is localized to a discrete area within the Golgi complex. Some
XL
s is also found at the plasma membrane (Figure 4A). The presence
of XL
s only in cells with both regulated and constitutive secretion
suggests that it may be involved in membrane trafficking. XL
s could
cycle between the plasma membrane and the Golgi and use its
Golgi-localization signals for targeting to a functional domain in the
Golgi involved in vesicle transport.
These results are the first to indicate that a PRR was critical for Golgi localization and suggest that, at least for G proteins, insertion of this region by alternative splicing may be a general mechanism for sorting and specific targeting. More studies are needed to determine if PRRs are a general localization signal for Golgi peripheral membrane proteins and the means and function of this targeting.
| |
ACKNOWLEDGMENTS |
|---|
We thank Dr. Wieland B. Huttner and Dr. Ralph H. Kelhenbach for
the XL
s cDNA, Dr. Regina Collins for cell culture expertise, Dr.
William F. Simonds for providing purified brain 
subunits, Dr.
April Robbins for advice, and Dr. Leonid Margolis and the National
Aeronautics and Space Administration/National Institutes of Health
Center for Three Dimensional Tissue Culture for assistance with the
confocal microscopy. This work was supported in part by a grant from
the Turkish Scientific and Technical Research Council (SBAG-2105).
| |
FOOTNOTES |
|---|
Corresponding author. E-mail address:
tlzj{at}helix.nih.gov.
| |
ABBREVIATIONS |
|---|
Abbreviations used:
AS, antibody for G
i;
FGF, fibroblast growth factor;
GFP, green fluorescent protein;
h, human;
IL, interleukin;
iLIF, intracellular leukemia inhibitory factor;
IRES, internal ribosome entry site;
LIF, leukemia inhibitory factor;
m, mouse;
PBST, PBS containing 0.1% Tween 20;
RM, antibody for
G
s.
| |
REFERENCES |
|---|
|
|
|---|
-subunit: neither farnesylation nor geranylgeranylation is sufficient for membrane attachment.
Biochemistry
31, 8030-8035[Medline].
i proteins to specific membrane domains.
J. Cell Sci.
107, 507-515[Abstract].
s subunit incorporates 3H-palmitic acid and mutation of cysteine-3 prevents this modification.
Biochemistry
32, 8057-8061[Medline].
subunit after activation by the
-adrenergic receptor or cholera toxin.
J. Biol. Chem.
268, 23769-23772
subunits and 
subunits of heterotrimeric G proteins on Golgi membranes of the exocrine pancreas.
J. Cell Biol.
133, 1027-1040
subunits.
Proc. Natl. Acad. Sci. USA
96, 412-417
by palmitate and the 
subunit.
Proc. Natl. Acad. Sci. USA
93, 14592-14597
subunits. In: G Proteins, ed. A.M. Spiegel,
T.L.Z. Jones,
W.F. Simonds, and
L.S. Weinstein, Austin, TX: R.G. Landes, 49-65.
12 requires acylation for its transforming activity.
Biochemistry
37, 3196-3202[Medline].
subunit is essential for its membrane attachment.
Proc. Natl. Acad. Sci. USA
87, 568-572
s is a new type of G protein.
Nature
372, 804-809[Medline].
s is a new type of G protein.
Nature
375, 253 (correction).
subunits are palmitoylated.
Proc. Natl. Acad. Sci. USA
90, 3675-3679
i2 to the Golgi by alternative spliced carboxyl-terminal region.
Science
263, 95-98
12 impairs activation through the thrombin receptor.
FEBS Lett.
429, 370-374[Medline].
-subunits in rat kidney.
Am. J. Physiol.
261, F831-F840
.
Cell
77, 1063-1070[Medline].
and Gs
.
J. Biol. Chem.
268, 25001-25008This article has been cited by other articles:
![]() |
A. I. Kaya, O. Ugur, S. S. Oner, M. Bastepe, and H. O. Onaran Coupling of {beta}2-Adrenoceptors to XL{alpha}s and G{alpha}s: A New Insight into Ligand-Induced G Protein Activation J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 350 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Plagge, G. Kelsey, and E. L Germain-Lee Physiological functions of the imprinted Gnas locus and its protein variants G{alpha}s and XL{alpha}s in human and mouse J. Endocrinol., February 1, 2008; 196(2): 193 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Linglart, M. J. Mahon, M. A. Kerachian, D. M. Berlach, G. N. Hendy, H. Juppner, and M. Bastepe Coding GNAS Mutations Leading to Hormone Resistance Impair in Vitro Agonist- and Cholera Toxin-Induced Adenosine Cyclic 3',5'-Monophosphate Formation Mediated by Human XL{alpha}s Endocrinology, May 1, 2006; 147(5): 2253 - 2262. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zheng, K. D. Butler, R. K. Tweten, and K. Mensa-Wilmot Endosomes, Glycosomes, and Glycosylphosphatidylinositol Catabolism in Leishmania major J. Biol. Chem., October 1, 2004; 279(40): 42106 - 42113. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hiol, P. C. Davey, J. L. Osterhout, A. A. Waheed, E. R. Fischer, C.-K. Chen, G. Milligan, K. M. Druey, and T. L. Z. Jones Palmitoylation Regulates Regulators of G-protein Signaling (RGS) 16 Function: I. MUTATION OF AMINO-TERMINAL CYSTEINE RESIDUES ON RGS16 PREVENTS ITS TARGETING TO LIPID RAFTS AND PALMITOYLATION OF AN INTERNAL CYSTEINE RESIDUE J. Biol. Chem., May 23, 2003; 278(21): 19301 - 19308. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nozawa, T. Daikoku, T. Koshizuka, Y. Yamauchi, T. Yoshikawa, and Y. Nishiyama Subcellular Localization of Herpes Simplex Virus Type 1 UL51 Protein and Role of Palmitoylation in Golgi Apparatus Targeting J. Virol., March 1, 2003; 77(5): 3204 - 3216. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bastepe, Y. Gunes, B. Perez-Villamil, J. Hunzelman, L. S. Weinstein, and H. Juppner Receptor-Mediated Adenylyl Cyclase Activation Through XL{alpha}s, the Extra-Large Variant of the Stimulatory G Protein {alpha}-Subunit Mol. Endocrinol., August 1, 2002; 16(8): 1912 - 1919. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Z. Yu and M. M. Rasenick Real-Time Visualization of a Fluorescent Galpha s: Dissociation of the Activated G Protein from Plasma Membrane Mol. Pharmacol., February 1, 2002; 61(2): 352 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Weinstein, S. Yu, D. R. Warner, and J. Liu Endocrine Manifestations of Stimulatory G Protein {alpha}-Subunit Mutations and the Role of Genomic Imprinting Endocr. Rev., October 1, 2001; 22(5): 675 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Pasolli, M. Klemke, R. H. Kehlenbach, Y. Wang, and W. B. Huttner Characterization of the Extra-large G Protein alpha -Subunit XLalpha s. I. TISSUE DISTRIBUTION AND SUBCELLULAR LOCALIZATION J. Biol. Chem., October 20, 2000; 275(43): 33622 - 33632. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Klemke, H. A. Pasolli, R. H. Kehlenbach, S. Offermanns, G. Schultz, and W. B. Huttner Characterization of the Extra-large G Protein alpha -Subunit XLalpha s. II. SIGNAL TRANSDUCTION PROPERTIES J. Biol. Chem., October 20, 2000; 275(43): 33633 - 33640. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||